Slingshot members are tracking this event:
Sangamo Therapeutics (SGMO) to submit IND in 2018 for cDNA gene therapy, which is designed to treat Fabry disease
Slingshot Insights Explained
Feb 20, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Cdna, Fabry Disease, Ind Filing